Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NEIL D LABOVE

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1033116025
CMS profile
677637
Location
WARWICK, RI

General Payments · PY2018–2020

$855.18

  • Reported across 58 records
  • CMS publication 2026-01-23

Latest program year · PY2020

$181.30

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2020 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $181.30 17

By paying entity

PY2020 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $181.30 17

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $505.20 33
PY2019 $168.68 8
PY2020 $181.30 17

Payment records · PY2020 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2020 20182019 Record-level detail is published for PY2020; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GlaxoSmithKline, LLC. $7.46 01/08/2020 Food and Beverage Undisputed 01/23/2026 738912585 CMS
GlaxoSmithKline, LLC. $97.28 01/09/2020 Food and Beverage Undisputed 01/23/2026 738648557 CMS
GlaxoSmithKline, LLC. $5.05 01/15/2020 Food and Beverage Undisputed 01/23/2026 738622763 CMS
GlaxoSmithKline, LLC. $5.59 01/21/2020 Food and Beverage Undisputed 01/23/2026 738551049 CMS
GlaxoSmithKline, LLC. $4.70 01/27/2020 Food and Beverage Undisputed 01/23/2026 738644677 CMS
GlaxoSmithKline, LLC. $6.78 02/13/2020 Food and Beverage Undisputed 01/23/2026 738550027 CMS
GlaxoSmithKline, LLC. $3.09 02/18/2020 Food and Beverage Undisputed 01/23/2026 738618615 CMS
GlaxoSmithKline, LLC. $3.39 02/24/2020 Food and Beverage Undisputed 01/23/2026 738679617 CMS
GlaxoSmithKline, LLC. $3.65 05/18/2020 Food and Beverage Undisputed 01/23/2026 738817489 CMS
GlaxoSmithKline, LLC. $6.73 06/01/2020 Food and Beverage Undisputed 01/23/2026 738551401 CMS
GlaxoSmithKline, LLC. $5.78 06/10/2020 Food and Beverage Undisputed 01/23/2026 738759407 CMS
GlaxoSmithKline, LLC. $7.05 06/23/2020 Food and Beverage Undisputed 01/23/2026 738551409 CMS
GlaxoSmithKline, LLC. $3.74 06/24/2020 Food and Beverage Undisputed 01/23/2026 738623379 CMS
GlaxoSmithKline, LLC. $4.28 07/14/2020 Food and Beverage Undisputed 01/23/2026 738602165 CMS
GlaxoSmithKline, LLC. $5.33 07/30/2020 Food and Beverage Undisputed 01/23/2026 738725801 CMS
GlaxoSmithKline, LLC. $5.76 08/05/2020 Food and Beverage Undisputed 01/23/2026 738654699 CMS
GlaxoSmithKline, LLC. $5.64 08/25/2020 Food and Beverage Undisputed 01/23/2026 738731715 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.